{"id":49364,"date":"2021-05-11T10:45:47","date_gmt":"2021-05-11T14:45:47","guid":{"rendered":"https:\/\/www.simonssearchlight.org\/2021\/05\/11\/i-nostri-partecipanti-ripartizione-per-il-10-anniversario\/"},"modified":"2021-05-11T10:45:47","modified_gmt":"2021-05-11T14:45:47","slug":"i-nostri-partecipanti-ripartizione-per-il-10-anniversario","status":"publish","type":"post","link":"https:\/\/www.simonssearchlight.org\/it\/2021\/05\/11\/i-nostri-partecipanti-ripartizione-per-il-10-anniversario\/","title":{"rendered":"I nostri partecipanti: Ripartizione per il 10\u00b0 anniversario"},"content":{"rendered":"<p>Negli ultimi 10 anni, <span class=\"notranslate\">Simons Searchlight<\/span> si \u00e8 evoluto fino a includere pi\u00f9 di 150 condizioni genetiche. Nell&#8217;ambito della nostra revisione decennale, stiamo esaminando i partecipanti alla nostra comunit\u00e0.<\/p>\n<p style=\"padding-left: 30px;\">&#8220;<em>Lavorando a stretto contatto con le famiglie di tutte le nostre condizioni negli ultimi 10 anni, possiamo constatare una cosa: ogni bambino \u00e8 un individuo, ma siamo pi\u00f9 simili che diversi. I trattamenti per le sfide dello sviluppo, in particolare, possono richiedere una valutazione personalizzata e la medicina di precisione, ma saranno anche guidati dalla nostra forza numerica&#8221;.<\/em><\/p>\n<p style=\"padding-left: 30px;\"><strong>LeeAnne Green Snyder<br \/>\n<\/strong><strong>Psicologo clinico autorizzato, ricercatore clinico, <span class=\"notranslate\">Simons Searchlight<\/span><\/strong><\/p>\n<p>Ad oggi, sono oltre 4.000 le famiglie iscritte a <span class=\"notranslate\">Simons Searchlight<\/span>. Di seguito sono riportati i numeri di registrazione suddivisi per condizione genetica. Il primo grafico comprende i gruppi genetici con pi\u00f9 di 20 famiglie registrate, mentre il secondo grafico comprende i gruppi genetici con 5-19 famiglie registrate.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-10675\" src=\"https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053138\/n_families.jpg\" alt=\"\" width=\"1429\" height=\"863\" srcset=\"https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053138\/n_families.jpg 1429w, https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053138\/n_families-300x181.jpg 300w, https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053138\/n_families-768x464.jpg 768w, https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053138\/n_families-1024x618.jpg 1024w\" sizes=\"(max-width: 1429px) 100vw, 1429px\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-10676\" src=\"https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053141\/n_families2.jpg\" alt=\"\" width=\"1302\" height=\"842\" srcset=\"https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053141\/n_families2.jpg 1302w, https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053141\/n_families2-300x194.jpg 300w, https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053141\/n_families2-768x497.jpg 768w, https:\/\/cdn.simonssearchlight.org\/wp-content\/uploads\/2021\/05\/11053141\/n_families2-1024x662.jpg 1024w\" sizes=\"(max-width: 1302px) 100vw, 1302px\" \/><\/p>\n<p>I partecipanti a <span class=\"notranslate\">Simons Searchlight<\/span> sono invitati a completare un&#8217;intervista anamnestica (MHI) per telefono con i nostri consulenti genetici. Di seguito sono riportate due tabelle con le informazioni fornite dai partecipanti al <span class=\"notranslate\">Simons Searchlight<\/span>. Non sono inclusi i dati di altre ricerche pubblicate. Queste tabelle includono persone con varianti classificate come patogene o probabilmente patogene. Le varianti di incerta rilevanza (VUS) non sono incluse. Le persone con una VUS sono invitate a partecipare e ogni anno rivalutiamo le varianti classificate come VUS.<\/p>\n<p>&nbsp;<\/p>\n<p>La prima tabella<strong>(Tabella 1<\/strong>) comprende i gruppi genetici con interviste anamnestiche completate su almeno 10 partecipanti. La tabella 1 contiene la percentuale (%) di persone che riferiscono disturbi dello spettro autistico (ASD), ritardi nello sviluppo o disabilit\u00e0 intellettiva (DD\/ID) e crisi epilettiche.<\/p>\n<p><strong>Tabella 1. Gruppi genetici con 10 o pi\u00f9 MHI completati (22 gruppi).<\/strong><\/p>\n<table style=\"width: 100%; border: 1px solid black;\">\n<tbody>\n<tr>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Variante genica\/numero di copia<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Numero di persone con MHI<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>ASD (numero) %<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>DD\/ID (numero) %<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Convulsioni (numero) %<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>Delezione 1q21.1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">47<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(11) 23%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(17) 36%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(3) 6%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>Duplicazione 1q21.1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">45<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(13) 29%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(15) 33%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(3) 7%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>Delezione 16p11.2<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">156<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(50) 32%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(76) 49%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(42) 27%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>Delezione distale 16p11.2<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">10<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(2) 20%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(5) 50%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(1) 10%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>ADNP<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">16<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(11) 69%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(14) 88%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(4) 25%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>ASXL3<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">16<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(11) 69%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(14) 88%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(4) 25%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>CAMPIONE1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">19<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(4) 21%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(13) 68%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(3) 16%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>CSNK2A1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">21<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(6) 29%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(18) 86%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(8) 38%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>CTNNB1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">31<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(4) 13%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(22) 71%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(0) 0%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>DYRK1A<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">22<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(10) 45%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(17) 77%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(11) 50%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>GRIN2B<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">42<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(11) 26%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(33) 79%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(7) 17%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>HIVEP2<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">15<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(5) 33%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(11) 73%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(1) 7%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>HNRNPH2<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">19<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(3) 16%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(19) 100%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(4) 21%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>MED13L<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">19<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(9) 47%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(17) 89%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(1) 5%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>PACS1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">20<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(10) 50%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(19) 95%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(9) 45%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>PPP2R5D<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">58<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(19) 33%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(51) 88%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(27) 47%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>SCN2A<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">83<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(36) 43%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(68) 82%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(63) 75%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>SETBP1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">17<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(3) 18%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(10) 59%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(1) 6%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>SLC6A1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">37<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(12) 32%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(27) 73%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(30) 81%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>STXBP1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">64<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(23) 36%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(49) 77%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(54) 84%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>SYNGAP1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">30<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(15) 50%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(23) 77%<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">(23) 77%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>La seconda tabella<strong>(Tabella 2<\/strong>) comprende i gruppi genetici con 5-9 interviste anamnestiche completate. Questa tabella riassume il numero totale di persone che hanno riferito disturbi dello spettro autistico (ASD), ritardi nello sviluppo o disabilit\u00e0 intellettiva (DD\/ID) e crisi epilettiche. Con maggiori informazioni e partecipanti, saremo in grado di fornire un quadro clinico migliore di queste condizioni genetiche.<\/p>\n<p><strong>Tabella 2. Gruppi genetici con 5-9 MHI completati (7 gruppi).<\/strong><\/p>\n<table style=\"width: 100%; border: 1px solid black;\">\n<tbody>\n<tr>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Variante genica\/numero di copia<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Numero di persone con MHI<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Numero ASD<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Numero di DD\/ID<\/strong><\/td>\n<td style=\"color: white; background-color: #f36046; text-align: center; padding: 5px; border: 1px solid #d9d9d9;\"><strong>Numero di sequestro<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>Duplicazione 7q11.23<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">4<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">4<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">2<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>ARID1B<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">1<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">4<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>CHD2<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">8<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">5<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">8<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>CHD8<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">5<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>FOXP1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">3<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">3<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">2<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>GRIN1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">1<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">6<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">3<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 5px; border: 1px solid #d9d9d9;\"><strong>PTCHD1<\/strong><\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">5<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">1<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">4<\/td>\n<td style=\"text-align: center; padding: 5px; border: 1px solid #d9d9d9;\">1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Negli ultimi 10 anni, Simons Searchlight si \u00e8 evoluto fino a includere pi\u00f9 di 150 condizioni genetiche. Nell&#8217;ambito della nostra revisione decennale, stiamo esaminando i partecipanti alla nostra comunit\u00e0. &#8220;Lavorando a stretto contatto con le famiglie di tutte le nostre condizioni negli ultimi 10 anni, possiamo constatare una cosa: ogni bambino \u00e8 un individuo, ma [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":49292,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[532],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/posts\/49364"}],"collection":[{"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/comments?post=49364"}],"version-history":[{"count":0,"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/posts\/49364\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/media\/49292"}],"wp:attachment":[{"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/media?parent=49364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/categories?post=49364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/it\/wp-json\/wp\/v2\/tags?post=49364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}